PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 6 filers reported holding PDL BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $67,000 | -88.5% | 22,916 | -89.2% | 0.00% | -83.3% |
Q4 2017 | $581,000 | +1470.3% | 212,019 | +1845.1% | 0.01% | – |
Q3 2017 | $37,000 | +37.0% | 10,900 | -1.8% | 0.00% | – |
Q2 2017 | $27,000 | +3.8% | 11,100 | -3.5% | 0.00% | – |
Q1 2017 | $26,000 | +8.3% | 11,503 | 0.0% | 0.00% | – |
Q4 2016 | $24,000 | -79.5% | 11,503 | -67.0% | 0.00% | -100.0% |
Q3 2016 | $117,000 | -7.9% | 34,858 | -2.9% | 0.00% | -33.3% |
Q4 2015 | $127,000 | -41.7% | 35,904 | -17.3% | 0.00% | -50.0% |
Q3 2015 | $218,000 | -99.9% | 43,439 | +4.2% | 0.01% | 0.0% |
Q2 2015 | $268,089,000 | +90165.7% | 41,693 | -1.1% | 0.01% | 0.0% |
Q1 2015 | $297,000 | -99.9% | 42,157 | +29.1% | 0.01% | +20.0% |
Q4 2014 | $251,732,000 | +7.9% | 32,650 | +4.5% | 0.01% | 0.0% |
Q3 2014 | $233,400,000 | -27.4% | 31,245 | -5.9% | 0.01% | -28.6% |
Q2 2014 | $321,415,000 | +14.0% | 33,204 | -2.1% | 0.01% | 0.0% |
Q1 2014 | $281,967,000 | +0.6% | 33,931 | +2.2% | 0.01% | 0.0% |
Q4 2013 | $280,183,000 | +6.4% | 33,197 | +0.5% | 0.01% | -12.5% |
Q3 2013 | $263,378,000 | – | 33,046 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |